Oncology & Cancer

AstraZeneca cancer drug, companion test approved

U.S. regulators on Friday granted accelerated approval to the first in a new class of targeted drugs for ovarian cancer, Lynparza from British drugmaker AstraZeneca PLC.

Vaccination

AstraZeneca, Oxford Uni buoyed by vaccine response

British pharma giant AstraZeneca said on Monday trials of its coronavirus vaccine pioneered with Oxford University had shown "encouraging" responses among elderly, as well as younger participants.

Medications

AstraZeneca suffers diabetes drug setback for COVID

British pharmaceutical giant AstraZeneca on Monday said that following a trial, its diabetes drug Farxiga was not successful in treating COVID patients at risk of severe complications.

Other

AstraZeneca profits soar on cancer drugs, Alexion buy

Anglo-Swedish drugmaker AstraZeneca on Thursday posted surging annual net profit, boosted by cancer treatments and the integration of biotech unit Alexion following a blockbuster takeover.

Vaccination

Spain limits AstraZeneca jab to the under-55s

Spain said on Friday it would limit use of the AstraZeneca vaccine to people under 55, becoming the latest European nation to impose an age restriction on the Anglo-Swedish jab.

page 6 from 34